abrdn Healthcare Investors |
HQH |
πΊπΈ |
New York Stock Exchange |
$862mn |
|
abrdn Healthcare Opportunities Fund |
THQ |
πΊπΈ |
New York Stock Exchange |
$836mn |
|
Ambu AS - Class B Shares |
AMBU B |
π©π° |
Copenhagen Stock Exchange |
kr.28.1bn |
STOXX600 |
Augmedix Inc |
AUGX |
πΊπΈ |
NASDAQ |
$122mn |
|
Avita Medical Limited |
AVH |
π¦πΊ |
Australian Stock Exchange |
AU$963mn |
|
Baxter International Inc. |
BAX |
πΊπΈ |
New York Stock Exchange |
$18.3bn |
S&P 100 S&P 500 |
Bellevue Healthcare Trust Plc |
BBH |
π¬π§ |
London Stock Exchange |
Β£655mn |
|
Cardinal Health, Inc. |
CAH |
πΊπΈ |
New York Stock Exchange |
$23.9bn |
S&P 500 |
CareCloud Inc |
MTBC |
πΊπΈ |
NASDAQ |
$21mn |
|
CareTech Holdings Plc |
CTH |
π¬π§ |
London Stock Exchange |
Β£850mn |
|
Centene Corp. |
CNC |
πΊπΈ |
New York Stock Exchange |
$41.4bn |
S&P 500 |
Cerner Corp. |
CERN |
πΊπΈ |
NASDAQ |
$27.9bn |
NASDAQ 100 S&P 500 |
Chr. Hansen Holding |
CHR |
π©π° |
Copenhagen Stock Exchange |
kr.72.5bn |
OMX Copenhagen 20 STOXX600 |
Cigna Group (The) |
CI |
πΊπΈ |
New York Stock Exchange |
$99.7bn |
S&P 500 |
Clariane SE |
CLARI |
π«π· |
Euronext Paris |
β¬361mn |
|
Clinica Baviera |
CBAV |
πͺπΈ |
Madrid Stock Exchange |
β¬462mn |
|
Coloplast AS - Class B Shares |
COLO B |
π©π° |
Copenhagen Stock Exchange |
kr.177.7bn |
STOXX600 OMX Copenhagen 20 |
Cooper Companies, Inc. |
COO |
πΊπΈ |
NASDAQ |
$18.8bn |
S&P 500 |
Craneware Plc |
CRW |
π¬π§ |
London Stock Exchange |
Β£830mn |
|
Creo Medical Group Plc |
CREO |
π¬π§ |
London Stock Exchange |
Β£126mn |
|
Danaher Corp. |
DHR |
πΊπΈ |
New York Stock Exchange |
$186.2bn |
S&P 500 |
DarioHealth Corp |
DRIO |
πΊπΈ |
NASDAQ |
$49mn |
|
DaVita Inc |
DVA |
πΊπΈ |
New York Stock Exchange |
$12.1bn |
S&P 500 |
Demant AS |
DEMANT |
π©π° |
Copenhagen Stock Exchange |
kr.71.8bn |
STOXX600 |
DENTSPLY Sirona Inc |
XRAY |
πΊπΈ |
NASDAQ |
$5.9bn |
NASDAQ 100 S&P 500 |
Edwards Lifesciences Corp |
EW |
πΊπΈ |
New York Stock Exchange |
$52.7bn |
S&P 500 |
EKF Diagnostics Holdings plc |
EKF |
π¬π§ |
London Stock Exchange |
Β£130mn |
|
Elekta AB - Class B Shares |
EKTA B |
πΈπͺ |
Stockholm Stock Exchange |
kr29.2bn |
STOXX600 |
Elevance Health Inc |
ELV |
πΊπΈ |
New York Stock Exchange |
$125.2bn |
S&P 500 |
EssilorLuxottica |
EL |
π«π· |
Euronext Paris |
β¬93.3bn |
Euro Stoxx 50 CAC 40 Euronext 100 STOXX600 |
Essity Aktiebolag (publ) - Class B Shares |
ESSITY B |
πΈπͺ |
Stockholm Stock Exchange |
kr178.0bn |
STOXX600 |
Euroapi S.A. |
EAPI |
π«π· |
Euronext Paris |
β¬294mn |
|
Fresenius Medical Care AG & Co. KGaA |
FME |
π©πͺ |
Frankfurt Stock Exchange |
β¬11.4bn |
DAX 40 FTSE Eurotop 100 STOXX600 |
Fresenius Medical Care AG & Co. KGaA - ADR |
FMS |
πΊπΈ |
New York Stock Exchange |
$12.2bn |
|
Fresenius SE & Co. KGaA |
FRE |
π©πͺ |
Frankfurt Stock Exchange |
β¬15.7bn |
DAX 40 STOXX600 |
Galenica AG |
GALE |
π¨π |
SIX Swiss Exchange |
Fr.3.6bn |
STOXX600 |
Geberit AG |
GEBN |
π¨π |
SIX Swiss Exchange |
Fr.19.3bn |
STOXX600 |
Haemonetics Corp. |
HAE |
πΊπΈ |
New York Stock Exchange |
$4.7bn |
|
HCA Healthcare Inc |
HCA |
πΊπΈ |
New York Stock Exchange |
$84.3bn |
S&P Global 100 S&P 500 |
Henry Schein Inc. |
HSIC |
πΊπΈ |
NASDAQ |
$9.4bn |
NASDAQ 100 S&P 500 |
Humana Inc. |
HUM |
πΊπΈ |
New York Stock Exchange |
$40.3bn |
S&P 500 |
Inspecs Group Plc |
SPEC |
π¬π§ |
London Stock Exchange |
Β£78mn |
|
Inspiration Healthcare Group Plc |
IHC |
π¬π§ |
London Stock Exchange |
Β£11mn |
|
Intuitive Surgical Inc |
ISRG |
πΊπΈ |
NASDAQ |
$136.7bn |
NASDAQ 100 S&P 500 |
IQVIA Holdings Inc |
IQV |
πΊπΈ |
New York Stock Exchange |
$41.8bn |
S&P 500 |
Kromek Group Plc |
KMK |
π¬π§ |
London Stock Exchange |
Β£42mn |
|
Mediclinic International Plc |
MDC |
π¬π§ |
London Stock Exchange |
Β£3.7bn |
FTSE 350 CBOE 100 CBOE 350 FTSE 250 |
Molina Healthcare Inc |
MOH |
πΊπΈ |
New York Stock Exchange |
$20.5bn |
S&P 500 |
National Healthcare Corp. |
NHC |
πΊπΈ |
Markets exchange |
$1.5bn |
|
Novacyt |
ALNOV |
π«π· |
Euronext Paris |
β¬56mn |
|
Oragenics Inc |
OGEN |
πΊπΈ |
Markets exchange |
$6mn |
|
Orpea S.A. |
ORP |
π«π· |
Euronext Paris |
β¬2.2bn |
STOXX600 |
PHSC |
PHSC |
π¬π§ |
London Stock Exchange |
Β£2mn |
|
Poolbeg Pharma Plc |
POLB |
π¬π§ |
London Stock Exchange |
Β£68mn |
|
Pro Medicus |
PME |
π¦πΊ |
Australian Stock Exchange |
AU$12.2bn |
|
PureTech Health Plc |
PRTC |
π¬π§ |
London Stock Exchange |
Β£603mn |
FTSE 250 FTSE 350 |
Ramsay Health Care |
RHC |
π¦πΊ |
Australian Stock Exchange |
AU$11.6bn |
|
Renalytix Plc |
RENX |
π¬π§ |
London Stock Exchange |
Β£39mn |
|
Resmed Inc. |
RMD |
πΊπΈ |
New York Stock Exchange |
$31.9bn |
S&P 500 |
Resmed Inc. - Chess Depository Interest |
RMD |
π¦πΊ |
Australian Stock Exchange |
AU$47.3bn |
|
RUA Life Sciences Plc |
RUA |
π¬π§ |
London Stock Exchange |
Β£8mn |
|
Savaria Corp. |
SIS |
π¨π¦ |
Toronto Stock Exchange |
C$1.3bn |
|
Sensus Healthcare Inc |
SRTS |
πΊπΈ |
NASDAQ |
$62mn |
|
Smith & Nephew plc |
SN. |
π¬π§ |
London Stock Exchange |
Β£8.8bn |
FTSE 100 FTSE 350 CBOE 100 CBOE 350 STOXX600 |
Spire Healthcare Group Plc |
SPI |
π¬π§ |
London Stock Exchange |
Β£1.0bn |
CBOE 250 CBOE 350 FTSE 250 FTSE 350 |
Stericycle Inc. |
SRCL |
πΊπΈ |
NASDAQ |
$4.4bn |
NASDAQ 100 |
Straumann Holding AG |
STMN |
π¨π |
SIX Swiss Exchange |
Fr.19.1bn |
STOXX600 |
Stryker Corp. |
SYK |
πΊπΈ |
New York Stock Exchange |
$126.0bn |
S&P 500 |
Teladoc Health Inc |
TDOC |
πΊπΈ |
New York Stock Exchange |
$2.1bn |
|
Totally Health Plc |
TLY |
π¬π§ |
London Stock Exchange |
Β£14mn |
|
Trellus Health Plc |
TRLS |
π¬π§ |
London Stock Exchange |
Β£3mn |
|
Tristel |
TSTL |
π¬π§ |
London Stock Exchange |
Β£213mn |
|
Unitedhealth Group Inc |
UNH |
πΊπΈ |
New York Stock Exchange |
$466.5bn |
Dow Jones 30 S&P 100 S&P 500 |
Universal Health Services, Inc. - Class B Shares |
UHS |
πΊπΈ |
New York Stock Exchange |
$10.6bn |
S&P 500 |
Vifor Pharma AG |
VIFN |
π¨π |
SIX Swiss Exchange |
Fr.10.8bn |
STOXX600 |
Zepp Health Corporation - ADR |
ZEPP |
πΊπΈ |
New York Stock Exchange |
$27mn |
|
Zimmer Biomet Holdings Inc |
ZBH |
πΊπΈ |
New York Stock Exchange |
$25.0bn |
S&P 500 |
Zoetis Inc - Class A Shares |
ZTS |
πΊπΈ |
New York Stock Exchange |
$76.7bn |
S&P 500 |